Technicians work as King Philippe of Belgium visits the seat and lab of candidate vaccine against Covid-19 developer Janssen Pharmaceutica, on June 17, 2020 in Beerse, Belgium. A brand new biotech lab was recently established to perform Covid-19 diagnostic tests. Belgium takes a pioneering role in the fight against viral infectious diseases. (Photo: Olivier Matthys/Getty 

Provoking a flurry of critical reactions from health experts and lawmakers, the Trump administration announced Tuesday afternoon that it will not participate in the “global effort to develop, manufacture, and equitably distribute a coronavirus vaccine, in part because the World Health Organization is involved”—a decision the Washington Post said “could shape the course of the pandemic and the country’s role in health diplomacy” going forward. 

The purpose of the Covid-19 Vaccines Global Access (Covax) Facility is to “speed vaccine development and secure doses for all countries and distribute them to the most high-risk segment of each population,” explained the Post

While more than 170 countries are in negotiations to participate in Covax, Judd Deere, a spokesperson for the White House, told reporters that “The United States will continue to […]

Read the Full Article